Speaker

Dr Steve Kitchen PhD, FIBMS

Dr. Steve Kitchen is a Lead Clinical Scientist at the Sheffield Haemophilia and Thrombosis Centre, with over 30 years of expertise in coagulation and anticoagulation management. He also serves as the Scientific Director for the UK National and WHO International External Quality Assessment Schemes for Blood Coagulation. Recognised for his contributions to the field, Dr. Kitchen has received the Inga Marie Nilsson Award for haemophilia care and the Lifetime Achievement Award for his work in anticoagulation, alongside delivering hundreds of presentations at major international conferences.

Current positions:
• Lead Clinical Scientist, Dept of Coagulation, Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals. Centre is designated an International Haemophilia Training Centre by World Federation of Haemophilia
• Scientific Director, UK National External Quality Assessment Scheme for Blood Coagulation (2001 to date)
• Director WFH International External Quality Assessment Schemes for Blood Coagulation (2012 to date)
• Vice Chair Haemostasis, International Council for Standardisation in Haematology

Lecture Abstract

Interfering substances can have a major impact in the results of many coagulation tests. Screening tests such as APTT where test plasma is not diluted prior to analysis are particularly susceptible to such problems. Some effects are caused by drug therapy or by pathological changes in the circulating substances. Recently, there has been particular interest in the impact of haemolysis, bilirubin and lipids, particularly following the launch of automated checks for the presence of these substances in coagulation samples.The impact of these substances is not confined solely to instruments that rely on the photo-optical method. In this webinar, Dr. Steve Kitchen will discuss the impact of interfering substances such as haemolysis, icterus/bilirubin and lipids with a particular focus on screening tests performed using Sysmex CS and CN series analysers.